LPAR1
Lysophosphatidic acid receptor 1
Also known as: edg-2, EDG2, Gpcr26, LPA1, LPAR1_HUMAN, Mrec1.3, rec.1.3, vzg-1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92633
- Gene
- LPAR1
- Ensembl
- ENSG00000198121
- Chromosome
- 9
- Canonical length
- 364 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins
OverviewNCBI Gene
The integral membrane protein encoded by this gene is a lysophosphatidic acid (LPA) receptor from a group known as EDG receptors. These receptors are members of the G protein-coupled receptor superfamily. Utilized by LPA for cell signaling, EDG receptors mediate diverse biologic functions, including proliferation, platelet aggregation, smooth muscle contraction, inhibition of neuroblastoma cell differentiation, chemotaxis, and tumor cell invasion. Many transcript variants encoding a few different isoforms have been identified for this gene. [provided by RefSeq, Oct 2020]
Canonical amino-acid sequenceUniProt
364 residues, UniProt reviewed canonical sequence.
>Q92633|LPAR1
1 MAAISTSIPV ISQPQFTAMN EPQCFYNESI AFFYNRSGKH LATEWNTVSK LVMGLGITVC
61 IFIMLANLLV MVAIYVNRRF HFPIYYLMAN LAAADFFAGL AYFYLMFNTG PNTRRLTVST
121 WLLRQGLIDT SLTASVANLL AIAIERHITV FRMQLHTRMS NRRVVVVIVV IWTMAIVMGA
181 IPSVGWNCIC DIENCSNMAP LYSDSYLVFW AIFNLVTFVV MVVLYAHIFG YVRQRTMRMS
241 RHSSGPRRNR DTMMSLLKTV VIVLGAFIIC WTPGLVLLLL DVCCPQCDVL AYEKFFLLLA
301 EFNSAMNPII YSYRDKEMSA TFRQILCCQR SENPTGPTEG SDRSASSLNH TILAGVHSND
361 HSVVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LPAR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 220 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 220 nTPM
- midbrain: 185 nTPM
- basal ganglia: 172 nTPM
- hippocampal formation: 156 nTPM
- amygdala: 155 nTPM
- hypothalamus: 94 nTPM
Single-cell type
- oligodendrocytes: 856 nCPM
- fibro-adipogenic progenitors: 448 nCPM
- schwann cells: 412 nCPM
- microglia: 360 nCPM
- fibroblasts: 347 nCPM
- pituicytes/fscs: 255 nCPM
Immune cell
- eosinophil: 18 nTPM
- classical monocyte: 8.7 nTPM
- intermediate monocyte: 2.9 nTPM
- myeloid DC: 2.1 nTPM
- NK-cell: 2.1 nTPM
- total PBMC: 2.1 nTPM
Brain region
- white matter: 506 nTPM
- basal ganglia: 419 nTPM
- medulla oblongata: 396 nTPM
- midbrain: 350 nTPM
- thalamus: 325 nTPM
- amygdala: 297 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.71
- gnomAD pLI
- 0.19
- gnomAD missense Z
- 2.42
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-activating G protein-coupled receptor signaling pathway
- adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway
- bleb assembly
- cell chemotaxis
- cellular response to oxygen levels
- cerebellum development
- corpus callosum development
- G protein-coupled receptor signaling pathway
- myelination
- negative regulation of cAMP/PKA signal transduction
- negative regulation of cilium assembly
- negative regulation of neuron projection development
- neurogenesis
- oligodendrocyte development
- optic nerve development
- phospholipase C-activating G protein-coupled receptor signaling pathway
- positive regulation of apoptotic process
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of cytosolic calcium ion concentration
- positive regulation of dendritic spine development
- positive regulation of MAPK cascade
- positive regulation of Rho protein signal transduction
- positive regulation of smooth muscle cell chemotaxis
- positive regulation of stress fiber assembly
- regulation of cell shape
- regulation of postsynaptic neurotransmitter receptor internalization
- regulation of synaptic vesicle cycle
- cellular response to 1-oleoyl-sn-glycerol 3-phosphate
Molecular functions
- G protein-coupled receptor activity
- G-protein alpha-subunit binding
- lysophosphatidic acid binding
- lysophosphatidic acid receptor activity
- PDZ domain binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- G protein-coupled receptor, rhodopsin-like
- Lysophosphatidic acid receptor
- GPCR, rhodopsin-like, 7TM
- 7 transmembrane receptor (rhodopsin family)
- Lysophosphatidic acid receptor EDG-2
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LPAR1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LPAR1 as an antibody target. Whether an autoantibody or antibody against LPAR1 could matter depends on whether native LPAR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LPAR1 is annotated at the cell surface, where native LPAR1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label LPAR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...